New to Meducation?
Sign up
Already signed up? Log In
view moderators

LungNeoplasms

Category

Preview
0
7

FDA Expands Use of Nivolumab in Lung Cancer

The new use is in nonsquamous, non-small-cell lung cancer (NSCLC). The drug was approved for squamous NSCLC earlier in the year.  
medscape.com
almost 6 years ago
Preview
0
16

WCLC Presidential Symposium: Summary, Clinical Implications

Dr Gilberto Lopes reviews the four top abstracts from the 16th World Conference on Lung Cancer, including treatments for NSCLC as well as genomics and lung cancer prevention.  
medscape.com
almost 6 years ago
Preview
0
7

Aprepitant Decreases Cough in Patients With Lung Cancer

First antitussive trial in lung cancer patients identifies promising treatment for bothersome cough.  
medscape.com
almost 6 years ago
Preview
0
26

Prognosis in Lung Cancer: Evolution of TNM in Molecular Age

Find out about revisions to the TNM classification system -- now in its' 8th edition.  
medscape.com
almost 6 years ago
Preview
3
29

Lung cancer: diagnosis and management | Guidance and guidelines | NICE

This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.  
nice.org.uk
almost 6 years ago
Ht 151113 tagrisso pill 800x600
0
1

FDA OKs Osimertinib for Specific Non-Small-Cell Lung Cancers

A new drug is available for patients with non-small-cell lung cancer (NSCLC) who progress on epidermal growth-factor receptor inhibitors and who have a specific related mutation.  
medscape.com
almost 6 years ago
Preview
0
12

First-Line Nivolumab Monotherapy in Advanced NSCLC

Recent studies indicate that immune mechanisms play a vital role in the origin of lung cancer. Is distortion of immune checkpoints the chief culprit?  
medscape.com
almost 6 years ago